Product checks
Safety data from trials In a paper summarizing 6 randomized, double-blind, placebo-controlled human trials, AOD 9604 did not significantly affect IGF-1 levels, did not impair glucose tolerance, and no serious adverse events (SAEs) were attributed to AOD 9604
The most common causes are foods, medications, and infections
Take the First Step Towards Enhanced Energy and Wellness If youre struggling with fatigue, low energy, or other symptoms of B12 deficiency, B12 injections could be the solution youve been looking for
Our multi-peptide formula supports regrowth, strengthens strands, and restores confidencewithout harsh chemicals or filler ingredients
Single vs Split Dosing Given BPC-157s short half-life (less than 30 minutes), some users prefer splitting their daily dose into two administrations